BRP: A natural brain-targeted appetite suppressor with Ozempic-like promises
Stanford researchers report that BRP, a 12‑amino‑acid peptide discovered via AI, suppresses appetite by acting on the hypothalamus, leading to reduced food intake and fat loss in animals with no major side effects, potentially offering a more targeted obesity treatment than Ozempic; human trials are planned after animal safety and efficacy are demonstrated.
